Tretinoin Cream 0.025% is a topical prescription medicine containing 0.025% (0.25 mg/g) of tretinoin — the biologically active, acid form of vitamin A (all-trans retinoic acid). It is the lowest clinically used strength of tretinoin and is commonly prescribed as a starting dose, particularly for patients new to retinoids, those with sensitive skin, or those who experienced irritation at higher concentrations.
In Australia, tretinoin is classified as a Schedule 4 Prescription Only Medicine under the Therapeutic Goods Administration (TGA). It cannot be purchased without a valid prescription from a registered Australian medical practitioner. This classification reflects that it is a potent, active pharmaceutical ingredient with specific indications, side effects, and contraindications — including a strict requirement to avoid use in pregnancy.
The branded Stieva-A 0.025% cream was withdrawn from the Australian Register of Therapeutic Goods in April 2025 by its sponsor, GlaxoSmithKline. Tretinoin 0.025% continues to be available in Australia as a compounded preparation made to order by registered Australian compounding pharmacies under a valid prescription. ReTrieve® Cream (tretinoin 0.05%) is a still-registered branded option at a higher strength, prescribed where the higher concentration is clinically appropriate.
Tretinoin 0.025% is prescribed in Australia for three primary indications, often overlapping in the same patient.
Tretinoin is a first-line topical treatment for mild to moderate acne — particularly non-inflammatory acne (comedones, blackheads, whiteheads) and mild inflammatory acne (papules and pustules). It works by normalising the way cells inside hair follicles shed, preventing the build-up that creates the microcomedone — the starting point of every pimple. Unlike antibiotics or benzoyl peroxide, tretinoin treats acne at the root cause and helps prevent new lesions forming, not just dry out existing spots. See our full guide: Tretinoin for Acne in Australia.
In Australian patients — where cumulative UV exposure is among the highest in the world — photoageing (UV-induced fine lines, roughness, mottled pigmentation and laxity) is one of the most common reasons tretinoin is prescribed. At 0.025%, tretinoin stimulates collagen production in the dermis and speeds up the shedding of surface cells damaged by years of sun exposure. Visible improvement in skin texture and firmness builds over 6–12 months of consistent use.
Tretinoin accelerates cell turnover, which disperses concentrated melanin and moves pigmented cells to the surface where they are shed sooner. It also inhibits the transfer of melanin between cells. For this reason, it is frequently included in combination treatment regimens for melasma, post-inflammatory hyperpigmentation (PIH), and age spots — often combined with a hydroquinone or niacinamide formula under dermatological supervision. More detail: Tretinoin for Pigmentation & Melasma.
Key fact: Tretinoin is not a surface exfoliant. It penetrates skin cells and binds to retinoic acid receptors (RARs) in the cell nucleus, switching genes on and off that govern cell turnover, pore shedding, and collagen production. Everything tretinoin does flows from this single receptor-binding event.
The three downstream effects of receptor activation are:
For a full scientific explanation, see How Tretinoin Works on Skin: The Science Behind the Results.
Always follow your prescribing doctor's specific instructions. The guidance below reflects standard clinical practice in Australia.
Do not start with nightly application. Begin on alternate nights (every second or third night) for the first 2–4 weeks to allow your skin to adjust, then increase to nightly use once tolerability is established. If irritation persists, maintain the lower frequency until your next review.
Tretinoin works by changing gene expression and rebuilding tissue — not by surface reaction. Results are biological in pace, not cosmetic.
| Timeframe | What's happening | What you may notice |
| Weeks 1–4 | Cell turnover accelerates; skin adjusts to the new rate | Dryness, mild flaking, possible redness; some experience a tretinoin purge (temporary increase in breakouts) |
| Weeks 4–8 | Skin adapts to the higher turnover rate | Irritation settles; texture begins to improve; new breakouts slow |
| 2–4 months | Pore normalisation established; surface pigmentation dispersing | Clearer, smoother skin; early fading of dark spots; more even tone |
| 4–6 months | Continued collagen synthesis and pigmentation improvement | Noticeable reduction in fine lines; hyperpigmentation significantly lighter |
| 6–12 months+ | Dermal collagen remodelling fully established | Improved firmness and skin density; long-term anti-ageing benefit |
Most side effects are dose-dependent and application-technique-dependent. Using the correct amount (pea-sized), applying only to dry skin, and starting on alternate nights substantially reduces severity. Report any concerning or persistent side effects to your prescribing doctor.
Tretinoin is contraindicated in the following situations. This is not an exhaustive list — your prescribing doctor will assess your full medical history before prescribing.
Subscribe for member-only pricing, restock alerts, and evidence-based skincare guidance from Tretinoin Australia.